# FDA Inspection 1328368 - Lexamed, Ltd - July 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/lexamed-ltd/42936122-cd0a-41e2-8518-842768447376
Source feed: FDA_Inspections

> FDA Inspection 1328368 for Lexamed, Ltd on July 09, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1328368
- Company Name: Lexamed, Ltd
- Inspection Date: 2026-07-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Cincinnati District Office

## Related Documents

- [FDA Inspection 1176430 - 2022-08-04](https://www.keypedia.com/records/fda_inspections/lexamed-ltd/67bf6191-e42c-445a-ba51-e1970bfa2f1b)
- [FDA Inspection 955062 - 2015-11-05](https://www.keypedia.com/records/fda_inspections/lexamed-ltd/114d4a74-c122-4f6f-9598-f14dde7c09cc)
- [FDA Inspection 572516 - 2009-03-13](https://www.keypedia.com/records/fda_inspections/lexamed-ltd/87115cf8-0de1-471e-856b-9dfb606045c5)

Company: https://www.keypedia.com/companies/lexamed-ltd/b54f148c-75ae-4ec5-aee3-d675b90f3f88

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22